Time-restricted Eating for Postpartum Weight Loss
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jul 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a method called time-restricted eating to help new mothers who are struggling to lose weight after giving birth. Time-restricted eating means that participants will eat their meals within a specific time window each day, which may help with weight loss and overall health. The study will focus on women who are 18 years or older, have had a healthy pregnancy, and are currently 6 to 16 weeks postpartum. Participants should have a body mass index (BMI) of 25 or higher, indicating that they are overweight or obese.
To participate, women should not have serious health conditions like diabetes or cancer, and they should not be undergoing treatment for severe mental health issues. Also, they should not be on medications that could affect their weight or have participated in other weight loss programs recently. The trial is not yet recruiting participants, but if you meet the criteria, you could help researchers understand if this eating approach is a good option for postpartum weight loss. Participants will be supported throughout the study and can expect to learn more about healthy eating habits while contributing to important research.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age or older
- • Experienced a healthy singleton pregnancy
- • 6-16 weeks postpartum at enrollment
- • Body mass index ≥25 at enrollment
- • Willing to consent
- Exclusion Criteria:
- • Self-reported major health condition (such as renal disease, cancer, or Type 1 or Type 2 diabetes)
- • Current treatment for severe psychiatric disorder (such as schizophrenia)
- • Self-reported diagnosis of anorexia or bulimia
- • Current use of medication expected to significantly impact body weight
- • Current substance abuse
- • Participation in another dietary and/or weight management intervention postpartum
- • Performing overnight shiftwork \>1x/week
- • Regularly fasting ≥14 hr/day or completing twelve or more 24-hr fasts within the past year
- • Unable to understand and communicate in English
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Camille Worthington, PhD
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported